From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
Caleb is the Director of Informatics at the UK Dementia Research Institute and a leading voice in decoding the complexities of neurodegenerative disease. He reveals groundbreaking findings from his team’s work: surprising overlaps between Parkinson’s and diabetes, the discovery that existing hypertension medications may halve the risk of developing Parkinson’s, and a major new study exploring whether combining blood-pressure drugs with GLP-1 therapies (like Ozempic-type medications) could slow or even prevent the disease.
Caleb offers real reasons for optimism: that prevention may be within reach, that repurposed medications could help people sooner than expected, and that the next decade of brain-health research looks more promising than any before.
This is an episode filled with science, humanity, and genuine hope — for people living with Parkinson’s today, for those caring for them, and for anyone navigating life touched by neurodegenerative disease.
We'd love to hear your stories and your advice for anyone living with dementia - or if you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.
For further help and advice please visit
https://www.alzheimers.org.uk
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment